Cargando…
Preclinical and clinical study on [(18)F]DRKXH1: a novel β-amyloid PET tracer for Alzheimer’s disease
BACKGROUND: The deposition of β-amyloid (Aβ) in the brain is a biomarker of Alzheimer’s disease (AD). Highly sensitive Aβ positron emission tomography (PET) imaging plays an essential role in diagnosing and evaluating the therapeutic effects of AD. AIM: To synthesize a new Aβ tracer [(18)F]DRKXH1 (5...
Autores principales: | Xu, MiaoMiao, Guo, Jun, Gu, JiaCheng, Zhang, LinLin, Liu, ZiHao, Ding, Lin, Fu, HongLiang, Ma, YuFei, Liang, Sheng, Wang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803783/ https://www.ncbi.nlm.nih.gov/pubmed/34292345 http://dx.doi.org/10.1007/s00259-021-05421-0 |
Ejemplares similares
-
Amyloid-Targeting PET Tracer [(18)F]Flutemetamol Accumulates in Atherosclerotic Plaques
por: Hellberg, Sanna, et al.
Publicado: (2019) -
Diagnostic accuracy of (18)F amyloid PET tracers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis
por: Morris, Elizabeth, et al.
Publicado: (2015) -
Protocols for Dual Tracer PET/SPECT Preclinical Imaging
por: Blower, Julia E., et al.
Publicado: (2020) -
High Correlation of Static First-Minute-Frame (FMF) PET Imaging after (18)F-Labeled Amyloid Tracer Injection with [(18)F]FDG PET Imaging
por: Seiffert, Alexander P., et al.
Publicado: (2021) -
Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies
por: Kroth, Heiko, et al.
Publicado: (2019)